--- title: "Cytokine Modulators" ocid: "ocds-r6ebe6-0000631656" canonical_url: "https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000631656" markdown_url: "https://d3tenders.com/contract/ocds-r6ebe6-0000631656.md" json_url: "https://d3tenders.com/contract/ocds-r6ebe6-0000631656.json" source: "Public Contracts Scotland" current_stage: "Award" buyer: "THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (\"NSS\")" published: "2021-02-11" --- # Cytokine Modulators Buyer: THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("NSS") Current stage: Award OCID: ocds-r6ebe6-0000631656 [View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000631656) [Download OCDS JSON](https://d3tenders.com/contract/ocds-r6ebe6-0000631656.json) ## Summary The Common Services Agency (NHS National Services Scotland) is currently undertaking a procurement process for a contract titled "Cytokine Modulators" in the healthcare industry. This procurement is at the Award stage, with key components including a total contract value of £146,393,864, covering a period of 24 months with the possibility of a further 24-month extension. The contract involves the delivery of cytokine modulators in various specified categories (lots) to entities established under the National Health Service (Scotland) Act 1978 across various locations in the UK. The decision for awarding this contract was made on 11th January 2021, with electronic submissions being mandatory for this open procurement procedure. This tender presents substantial opportunities for businesses, particularly those involved in the pharmaceutical sector, such as suppliers of injectable medications and healthcare products. Given the nature of the goods involved, companies with expertise in manufacturing or supplying cytokine modulators, particularly those who can demonstrate compliance with stringent regulatory requirements, would be well-positioned to compete. With several lots available, both large and small enterprises can potentially participate, especially those equipped to meet the various technical and quality control criteria specified by NHS Scotland. ## Notice Supply of Cytokine Modulators to NHS Scotland which is used to treat licensed indications. Etanercept Infliximab Adalimumab Methotrexate The Goods have been split into eight (8) categories, each of which are identified as a "Lot". Full details of each Lot are contained in section II.2 of this notice. ### Lot Information Adalimumab Supply of Adalimumab to NHS Scotland. The Authority has awarded this Lot as a unranked multi-supplier framework per line to five (5) Framework Participants. Renewal: This framework includes the option(s) to extend for up to a total period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire. Etanercept Supply of Etanercept to NHS Scotland. The Authority has awarded this Lot as a unranked multi-supplier framework per line to three (3) Framework Participants. Renewal: This framework includes the option(s) to extend for up to a total period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire. Infliximab IV Supply of Infliximab IV to NHS Scotland. The Authority has awarded this Lot as a unranked multi-supplier framework per line to five (5) Framework Participants. Renewal: This framework includes the option(s) to extend for up to a total period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire. Methotrexate (50 mg per 1 ml concentration ) pre-filled self injection device Supply of Methotrexate (50 mg per 1 ml concentration ) pre-filled self injection device to NHS Scotland. The Authority has awarded this Lot as a unranked multi-supplier framework per line to two (2) Framework Participants. Renewal: This framework includes the option(s) to extend for up to a total period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire. Methotrexate (50 mg per 1 ml concentration ) pre-filled syringes Supply of Methotrexate (50 mg per 1 ml concentration ) pre-filled syringes to NHS Scotland. The Authority has awarded this Lot as a unranked multi-supplier framework per line to one (1) Framework Participant. Renewal: This framework includes the option(s) to extend for up to a total period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire. Methotrexate (25 mg per 1 ml concentration ) pre-filled self injection device Supply of Methotrexate (25mg per 1 ml concentration ) pre-filled self injection device to NHS Scotland. The Authority has awarded this Lot as a unranked multi-supplier framework per line to one (1) Framework Participant. Renewal: This framework includes the option(s) to extend for up to a total period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire. Methotrexate (25mg per 1 ml concentration ) pre-filled syringes Supply of Methotrexate (25 mg per 1 ml concentration) pre-filled syringes to NHS Scotland. The Authority has awarded this Lot as a unranked multi-supplier framework per line to one (1) Framework Participant. Renewal: This framework includes the option(s) to extend for up to a total period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire. Infliximab Subcutaneous Supply of Infliximab Subcutaneous to NHS Scotland. The Authority has awarded this Lot as a single supplier framework per line to one (1) Framework Participant. Renewal: This framework includes the option(s) to extend for up to a total period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire. ## Key Details | Field | Value | | --- | --- | | Publication source | Public Contracts Scotland | | Latest notice | https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=FEB406448 | | Notice type | OJEU - F3 - Contract Award Notice | | Procurement type | Framework | | Procurement category | Goods | | Procurement method | Open | | Procurement method details | Open procedure | | Tender suitability | Not specified | | Awardee scale | Large, SME | | All stages | Tender, Award | ## Dates | Field | Value | | --- | --- | | Publication date | 11 Feb 2021 | | Submission deadline | 12 Nov 2020 | | Future notice date | Not specified | | Award date | 11 Jan 2021 | | Contract period | Not specified | | Recurrence | Not specified | ## Values | Field | Value | | --- | --- | | Tender value | £146,393,864 | | Lots value | £146,393,863 | | Awards value | Not specified | | Contracts value | £116,643,215 | ## Status | Field | Value | | --- | --- | | Tender status | Complete | | Lots status | Complete | | Awards status | Not specified | | Contracts status | Active | ## Buyer | Field | Value | | --- | --- | | Main buyer | THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("NSS") | | Locality | EDINBURGH | | Post town | Edinburgh | | Postcode | EH12 9EB | | Country | Scotland | | ITL 1 | TLM Scotland | | ITL 2 | TLM1 East Central Scotland | | ITL 3 | TLM13 City of Edinburgh | | Local authority | City of Edinburgh | | Electoral ward | Drum Brae/Gyle | | Westminster constituency | Edinburgh South West | | Delivery location | TLM Scotland | ## Supplier | Field | Value | | --- | --- | | Number of suppliers | 12 | | Supplier names | ABBVIE; ACCORD; ACCORD-UK; AMGEN; BIOGEN IDEC; CELLTRION HEALTHCARE UNITED KINGDOM; FRESENIUS KABI; MEDAC PHARMA; MERCK SHARP & DOHME; NORDIC PHARMA; PFIZER; SANDOZ | ## CPV Codes ### Divisions - 33 - Medical equipments, pharmaceuticals and personal care products ### Codes - 33600000 - Pharmaceutical products ## Release History - 11 Feb 2021 at 00:00 - Award - OJEU - F3 - Contract Award Notice - https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=FEB406448 - 8 Oct 2020 at 00:00 - Tender - OJEU - F2 - Contract Notice - https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=OCT396897 ## Documents - https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=OCT396897 Cytokine Modulators - Supply of Cytokine Modulators to NHS Scotland. Etanercept Infliximab Adalimumab Methotrexate The Goods have been split into eight (8) categories, each of which are identified as a "Lot". Full details of each Lot are contained in section II.2 of this notice. - https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=FEB406448 Cytokine Modulators - Supply of Cytokine Modulators to NHS Scotland which is used to treat licensed indications. Etanercept Infliximab Adalimumab Methotrexate The Goods have been split into eight (8) categories, each of which are identified as a "Lot". Full details of each Lot are contained in section II.2 of this notice. ## Notice URLs - http:// - http://www.nhsscotlandprocurement.scot.nhs.uk/ - https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000631656 - https://www.publictendersscotland.publiccontractsscotland.gov.uk/web/login.html ## Provenance This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000631656. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-r6ebe6-0000631656.json.